| Dr Thomas A Beller, MD | |
|
6420 Prospect Avenue, T303, Kansas City, MO 64132 | |
| (816) 333-1919 | |
| (816) 361-1930 |
| Full Name | Dr Thomas A Beller |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 6420 Prospect Avenue, Kansas City, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033175062 | NPI | - | NPPES |
| 100195730A | Medicaid | KS | |
| 201193109 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | R9215 (Missouri) | Primary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 0416216 (Kansas) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas A Beller, MD 6420 Prospect Avenue, T303, Kansas City, MO 64132 Ph: (816) 333-1919 | Dr Thomas A Beller, MD 6420 Prospect Avenue, T303, Kansas City, MO 64132 Ph: (816) 333-1919 |
News Archive
Researchers at the University of Tennessee, Knoxville, have identified a set of bacterial genes that may help them find ways to lessen the severity of the disease malaria.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Notices of Allowance were recently issued by the United States Patent Office (USPTO) on patent applications filed by Thermo Fisher Scientific Inc. and licensed to RXi Pharmaceuticals encompassing small interfering RNA (siRNA) sequences targeting superoxide dismutase (SOD1), Amyloid beta (A4) precursor protein (APP), interleukin-1 receptor-associated kinase 4 (IRAK4), hepatocyte growth factor receptor (MET protooncogene) and cyclin-dependent kinase (cdk) inhibitor p27 (also known as Kip1, CDKN1B).
According to a new study television commercials for prescription drugs are heavily loaded on the emotional side but offer scant information on the disease itself and do little to promote the benefits of a healthy lifestyle.
A study at UCLA's Jonsson Comprehensive Cancer Center has found that head and neck cancer patients receiving radiation as part of their treatment were less likely to need a feeding tube or suffer unwanted side effects such as worsening of diet or narrowing of the throat passage if they performed a set of prescribed swallowing exercises - called a "swallow preservation protocol" - during therapy.
› Verified 2 days ago
Maria Akram Sheikh, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4401 Wornall Rd, Kansas City, MO 64111 Phone: 816-932-0340 Fax: 816-932-3148 | |
Dr. Philip Barigbi Augustine, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4150 N Mulberry Dr, Kansas City, MO 64116 Phone: 816-912-4539 Fax: 855-813-6642 | |
Lucas Vocelka, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2340 E Meyer Blvd, Bldg 2, Suite 392, Kansas City, MO 64132 Phone: 816-444-7977 Fax: 630-528-9578 | |
Karla L Houston-gray, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1004 Carondelet Dr Ste 300, Kansas City, MO 64114 Phone: 816-942-4500 Fax: 816-941-4504 | |
Carl D Dirks, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4320 Wornall Rd, Suite 65, Kansas City, MO 64111 Phone: 816-932-6100 Fax: 816-932-9002 | |
Michelle L Dew, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4330 Wornall Rd, Suite 2000, Kansas City, MO 64111 Phone: 816-931-1883 Fax: 816-756-3645 | |
Brenda J Rogers, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 |